Key result
Mavacamten effectively increased the myosin super-relaxed population in synthetic thick filaments of healthy and R403Q myosin, though elevated ADP weakened this effect.
Why the study?
Although synthetic thick filaments have been extensively used for structural characterization, their functional evaluation has been limited.
Synthetic thick filaments serve as a more physiologically relevant in vitro model than shorter myosin subfragments for evaluating the myosin super-relaxed state and the pharmacological effects of mavacamten.
No takes yet. Share an insight, caveat, or question.
Supports mavacamten mechanism studies in improved filament models; leaves open clinical translation pending human data.
Gollapudi et al. (2020) studied Hypertrophic cardiomyopathy. Mavacamten vs. S1 or HMM was evaluated on Myosin super-relaxed (SRX) population. Mavacamten effectively increased the myosin super-relaxed population in synthetic thick filaments of healthy and R403Q myosin, though elevated ADP weakened this effect.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: